Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

Drug Efficacy

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

Four Phase 3 studies reported meaningful symptom reductions across all age groups.

FDA Grants Full Approval to Jaypirca for Relapsed CLL/SLL After Covalent BTK Therapy

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings